Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.270 -0.050 (-3.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,255,246
Open 1.310
Bid (Size) 1.280 (1)
Ask (Size) 1.300 (47)
Prev. Close 1.320
Today's Range 1.270 - 1.330
52wk Range 1.090 - 4.825
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire

Performance

YTD
-64.7%
-64.7%
1 Month
-12.4%
-12.4%
3 Month
-18.1%
-18.1%
6 Month
-27.0%
-27.0%
1 Year
-71.8%
-71.8%

More News

Read More
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
Via Benzinga
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron (GERN) Q2 Revenue Jumps 5,477%
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
From Geron Corporation
Via Business Wire
Geron Appoints Harout Semerjian as President and Chief Executive Officer
From Geron Corporation
Via Business Wire
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron
From Faruqi & Faruqi, LLP
Via Business Wire
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN
From Faruqi & Faruqi LLP
Via GlobeNewswire
GERN Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Geron Corporation (GERN) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
GERN Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Geron Corporation (GERN) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
From Pomerantz LLP
Via GlobeNewswire
GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
GERN Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Geron Corporation (GERN) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
GERN Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Geron Corporation (GERN) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Geron, Digimarc, XPLR, and Fluence and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Geron Stock Crept Higher Today
Via The Motley Fool

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.270
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 09/12/25 04:00 PM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 646.13M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 646M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.